Clinical Trial Update: XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors [Phase 3]

View source ↗

Summary

A phase 3 trial comparing XL119 to 5-fluorouracil with leucovorin in adults with advanced biliary tract cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Leucovorin (folinic acid)
• XL119

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Biliary Tract Cancer | Phase 3 | Status: TERMINATED